Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
Saved in:
Main Authors: | Xin Zhang, Xiaojuan Yu, Suxia Wang, Yujun Dong, Minghui Zhao, Fude Zhou, Xiangxiang Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2025-01-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: a case report with 3 years of follow-up and review of the literature
by: Xueying Chen, et al.
Published: (2025-01-01) -
Daratumumab for Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allograft: A Case Report
by: Zewei Chen, et al.
Published: (2025-02-01) -
Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
by: Fang-Yu Wang, et al.
Published: (2023-04-01) -
Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition
by: Varinder K. Randhawa, et al.
Published: (2020-06-01) -
Daratumumab for autoimmune diseases: a systematic review
by: Martin Krusche, et al.
Published: (2023-12-01)